flow trial semaglutide kidney outcomes 2024 nejm hazard ratio 0.76 FLOW- the Visual Abstract — NephJC Treatment with sodium–glucose cotransporter 2 – flow trial semaglutide kidney outcomes

For now, the absence of cardiac damage signals in the phase 2 trial is reassuring but not definitive

Pancreatitis: There have been rare reports of pancreatitis (inflammation of the pancreas) associated with the use of GLP-1 medications, so close monitoring by a healthcare provider is essential

Eggs or egg whites Fish, chicken, turkey, or lean mince Tofu, tempeh, or lentils Cottage cheese When Solid Food Wont Cooperate, Go Liquid Many people on GLP-1 medication find that liquid protein goes down far more easily than a plateful of anything

The initial slowing of gastric emptying tends to diminish with ongoing treatment, though the appetite-suppressing effects generally persist